REPORT ID 3718

United States Veterinary Drugs Market Report 2017

Publish Date
14-Dec-17
Pages
98
Format
Electronic (PDF)

In this report, the United States Veterinary Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Veterinary Drugs in these regions, from 2012 to 2022 (forecast).

United States Veterinary Drugs market competition by top manufacturers/players, with Veterinary Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Zoetis
    Boehringer Ingelheim
    Bayer
    Elanco Animal Health
    Ceva
    Dechra
    Merck
    Virbac
    Vetoquinol

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Anti-infective
    Anti-inflammatory
    Parasiticides
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Veterinary Drugs for each application, including
    Livestock
    Companion

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Veterinary Drugs Market Report 2017
1 Veterinary Drugs Overview
    1.1 Product Overview and Scope of Veterinary Drugs
    1.2 Classification of Veterinary Drugs by Product Category
        1.2.1 United States Veterinary Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Veterinary Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Anti-infective
        1.2.4 Anti-inflammatory
        1.2.5 Parasiticides
    1.3 United States Veterinary Drugs Market by Application/End Users
        1.3.1 United States Veterinary Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Livestock
        1.3.3 Companion
    1.4 United States Veterinary Drugs Market by Region
        1.4.1 United States Veterinary Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Veterinary Drugs Status and Prospect (2012-2022)
        1.4.3 Southwest Veterinary Drugs Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Veterinary Drugs Status and Prospect (2012-2022)
        1.4.5 New England Veterinary Drugs Status and Prospect (2012-2022)
        1.4.6 The South Veterinary Drugs Status and Prospect (2012-2022)
        1.4.7 The Midwest Veterinary Drugs Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Veterinary Drugs (2012-2022)
        1.5.1 United States Veterinary Drugs Sales and Growth Rate (2012-2022)
        1.5.2 United States Veterinary Drugs Revenue and Growth Rate (2012-2022)

2 United States Veterinary Drugs Market Competition by Players/Suppliers
    2.1 United States Veterinary Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Veterinary Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Veterinary Drugs Average Price by Players/Suppliers (2012-2017)
    2.4 United States Veterinary Drugs Market Competitive Situation and Trends
        2.4.1 United States Veterinary Drugs Market Concentration Rate
        2.4.2 United States Veterinary Drugs Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Veterinary Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Veterinary Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Veterinary Drugs Sales and Market Share by Region (2012-2017)
    3.2 United States Veterinary Drugs Revenue and Market Share by Region (2012-2017)
    3.3 United States Veterinary Drugs Price by Region (2012-2017)

4 United States Veterinary Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Veterinary Drugs Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Veterinary Drugs Revenue and Market Share by Type (2012-2017)
    4.3 United States Veterinary Drugs Price by Type (2012-2017)
    4.4 United States Veterinary Drugs Sales Growth Rate by Type (2012-2017)

5 United States Veterinary Drugs Sales (Volume) by Application (2012-2017)
    5.1 United States Veterinary Drugs Sales and Market Share by Application (2012-2017)
    5.2 United States Veterinary Drugs Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Veterinary Drugs Players/Suppliers Profiles and Sales Data
    6.1 Zoetis
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Veterinary Drugs Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Zoetis Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Boehringer Ingelheim
        6.2.2 Veterinary Drugs Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Boehringer Ingelheim Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Bayer
        6.3.2 Veterinary Drugs Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Bayer Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Elanco Animal Health
        6.4.2 Veterinary Drugs Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Elanco Animal Health Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Ceva
        6.5.2 Veterinary Drugs Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Ceva Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Dechra
        6.6.2 Veterinary Drugs Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Dechra Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Merck
        6.7.2 Veterinary Drugs Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Merck Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Virbac
        6.8.2 Veterinary Drugs Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Virbac Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Vetoquinol
        6.9.2 Veterinary Drugs Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Vetoquinol Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Veterinary Drugs Manufacturing Cost Analysis
    7.1 Veterinary Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Veterinary Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Veterinary Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Veterinary Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Veterinary Drugs Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Veterinary Drugs Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Veterinary Drugs Sales Volume Forecast by Type (2017-2022)
    11.3 United States Veterinary Drugs Sales Volume Forecast by Application (2017-2022)
    11.4 United States Veterinary Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer